Prevalence of sleep disturbances in diabetes mellitus

doi:10.1016/0168-8227(94)90103-1

Diabetes Research and Clinical Practice

Volume 23, Issue 3, April 1994, Pages 183-186

https://doi.org/10.1016/0168-8227(94)90103-1 Get rights and content

Abstract

We studied the prevalence of sleep disturbances in 184 persons with diabetes, and 99 controls matched for age and sex. Sleep disorders were more common in diabetics (33.7% vs. 8.2% in controls; P < 0.01). Patients with sleep disturbances were younger than those with normal sleep, and had onset of diabetes at a younger age. There was a significant association of sleep disturbances with the presence of cough, dyspnea, nocturnal cramps, paresthesia and burning of soles. Sleep disturbances may be due to physical discomfort, psychosocial factors, fluctuations in metabolic control and perhaps also hypoinsulinemia. Quality of life is affected and coping with the disease is made difficult by sleep disorders. Thus, physicians caring for persons with diabetes must be able to recognize, diagnose and manage sleep disturbances in their patients, when they occur.

References (16)

J. Danguir
Sleep deficits in diabetic rats: restoration following chronic intravenous or intracerebrovascular infusions of insulin
Brain Res. Bull.
(1984)
R.C. Temple et al.
Insulin deficiency in non-insulin-dependent diabetes mellitus
Lancet
(1989)
C.M. Shapiro et al.
Sleep problems in patients with medical illness
BMJ
(1993)
T. Gislason et al.
Somatic diseases and sleep complaints
Acta Med. Scand.
(1987)
M.T. Hyppa et al.
Quality of sleep and chronic illnesses
J. Clin. Epidemiol.
(1989)
A. Ramachandran et al.
High prevalence of diabetes in an urban population of S. India
BMJ
(1988)
G.R. Sridhar
Epidemiology of diabetes mellitus in emigrant Indians
Diabetes Bull., Res. Soc. Study Diabetes India
(1986)
G.R. Sridhar
Sleep disorders in India
J. Assoc. Physicians India
(1993)

There are more references available in the full text version of this article.

Cited by (118)

Sleep loss associated with medical conditions and diseases
2023, Encyclopedia of Sleep and Circadian Rhythms: Volume 1-6, Second Edition
Sleep deprivation has become a global problem with the development of a 24 h society and technological advances but is also associated with a variety of medical problems. Individuals with chronic medical conditions are particularly prone to poor sleep secondary to the disease process itself or associated symptoms, which can severely impact sleep architecture, timing, and duration. Although each disease can disrupt sleep by different mechanisms, it results in fatigue, malaise, excessive daytime sleepiness, or inability to sleep leading to poor daytime functioning and quality of life. Furthermore, a reciprocal relationship exists impairment of sleep and various medical problems (Fig. 1). The lack of quality and quantity of sleep can further exacerbate the underlying medical condition, associated symptoms, and daytime functioning.
Immune, neuroendocrine, and metabolic functions in insomnia disorder
2023, Encyclopedia of Sleep and Circadian Rhythms: Volume 1-6, Second Edition
Substantial evidence supports that insomnia prospectively increases risks for developing a wide range of diseases, including cardiovascular, metabolic, neurodegenerative, autoimmune, carcinogenic diseases, and pain disorders. The mechanisms underlying increased disease risks in individuals suffering from insomnia are an active area of research and involve dysregulations of multiple biological systems, including immune, neuroendocrine, and metabolic processes. Dysregulations in these physiological domains as they have been observed in insomnia disorder will be reviewed and their potential in mediating increased disease risk will be discussed.
Characterising the relationship between sleep stages and associated spectral power in diabetes
2022, Sleep Epidemiology
Sleep disturbances are prevalent in the UK and globally, with sleep data from across 13 countries suggesting that only 55% of adults are satisfied with their sleep. Disturbed sleep is found in diabetes which is one of the most serious diseases worldwide. Specifically, relationships have been found between glycaemic control and sleep duration and quality. It is currently unclear how diabetes specifically affects sleep stages, and their associated spectral power. This study aims to characterise the relationship between polysomnography-measured specific sleep stages and associated spectral power in adults with diabetes and control participants. This study involved a secondary data analysis of multi-cohort Sleep Heart Health (SHH) data using a matched-pairs design. The sample included 414 participants (211 males, 203 females, mean age (years) 70.0, 95% CI [69.1, 70.9]) 207 with diabetes and 207 matched controls. The results suggest an increase in light sleep in diabetes, specifically NREM stage 2 sleep duration (p = 0.05) and percentage (p = 0.04), with an increase in slow-wave activity (p = 0.03) and delta power (p = 0.04) during NREM stage 1 sleep. Slow-wave sleep duration marginally reduced in diabetes, (p = 0.09), whilst delta power (p < 0.01), slow-wave activity (p = 0.02) and theta power (p < 0.01) in slow-wave sleep also significantly reduced in diabetes compared to control participants. No other changes to sleep stages or associated spectral power were observed. These results suggest a potential homoeostatic influence of sleep on glycaemic control, which should be further explored in future research.
Effects of cognitive behavioral therapy on sleep disturbances and quality of life among adults with type 2 diabetes mellitus: A randomized controlled trial
2020, Nutrition, Metabolism and Cardiovascular Diseases
Citation Excerpt :
Sleep disturbance, such as poor sleep quality, is common in individuals with type 2 diabetes mellitus (T2DM), with a prevalence of 25–70% in different populations [1–3], and patients with T2DM had more frequency of sleep disturbance than controls without T2DM matched by age and sex [1,4].
Cognitive behavioral therapy (CBT) is recommended as the first-line nonpharmacotherapy for sleep complaints. However, there are no studies that tested CBT for improving sleep quality and increasing quality of life (QOL) in patients with type 2 diabetes mellitus (T2DM). Therefore, this study aims to test the effect of CBT on sleep disturbances and QOL in patients with T2DM.
In total, 187 participants with T2DM and comorbid poor sleep quality were included in the analysis with the control group of 93 receiving usual care (UC) only and the intervention group of 94 receiving CBT with aerobic exercise plus UC, The Pittsburgh Sleep Quality Index (PSQI), the Diabetes-Specific Quality of Life Scale (DSQLS) and the glycated hemoglobin (HbA1C) values were collected at baseline, after the 2-month intervention, and 6 months of follow-up. The CBT group had 3.03 points lower PSQI scores (95% confidence interval [CI]: 2.07–4.00, P < 0.001) and 7.92 points lower total DSQLS scores (95% CI: 4.98–10.87, P < 0.001) than the control group after 6-month follow-up. No difference was found in HbAlc between the two groups (t = −0.47, P = 0.64) after 2-month intervention, while the CBT group had 0.89 units lower HbAlc (95% CI: 0.49–1.28, P < 0.001) than the control group after 6-month follow-up.
CBT is effective for sleep disturbances and can also improve sleep quality, increase QOL, and decrease glycemic levels in participants with T2DM.
Chinese Clinical Trials Registration (Practical study of the appropriate technique for improvement of quality of life of the patients with type 2 diabetes in communities: ChiCTR-IOP-16008045).
Dietary total antioxidant capacity and its association with sleep, stress, anxiety, and depression score: A cross-sectional study among diabetic women
2020, Clinical Nutrition ESPEN
Diabetes as a common chronic disease leads to several serious disabilities and complications. Patients with type 2 diabetes are involved with psychological and sleep disorders which diet can be effective in the management of these problems. The present study aimed to investigate the association of Dietary Total Antioxidant Capacity (DTAC) and sleep, stress, anxiety, and depression among diabetic women.
This cross-sectional study conducted on 265 women with type 2 diabetes. A validated food frequency questionnaire was filled to evaluate dietary intakes. We calculated DTAC based on amounts of antioxidant in each dietary item using the ferric reducing ability of plasma (FRAP) and oxygen radical absorbance capacity (ORAC) databases. Pittsburgh Sleep Quality Index was used to assess sleep quality. Moreover, 21 items Depression, Anxiety, and Stress Scale was used to assess mental disorders.
Subjects in the highest tertile of FRAP and ORAC score compared to those in the lowest tertile of these scores had 94% and 87% lower risk of poor sleep, respectively. The odds of depression were negatively related to the highest tertile of FRAP and ORAC score (OR: 0.21, 95%CI: 0.09–0.50 and OR: 0.21, 95%CI: 0.10–0.48, respectively). Participants with the highest tertile of FRAP compared to those within the lowest tertile of FRAP score had a 59% lower risk of anxiety. The odds of stress were negatively related to the highest tertile of FRAP and ORAC score (OR: 0.10, 95%CI: 0.04–0.23 and OR: 0.13, 95%CI: 0.06–0.29, respectively).
There is a significant association between DTAC, sleep status and psychological disorders. However, prospective studies in both genders should be conducted to confirm the actual relationship.
Sleep duration is a significant predictor of cardiac autonomic neuropathy in type 2 diabetes mellitus
2019, Primary Care Diabetes
To investigate the association between sleep quality outcomes and measures of cardiac autonomic function and to assess the predictive ability of sleep quality outcomes for cardiac autonomic neuropathy (CAN) in type 2 diabetes mellitus (T2DM).
Fifty patients with T2DM (age, 51.3 ± 7.01 years; glycemic control, 8.4 ± 1.65%) completed the study. Patients were diagnosed for CAN using the standard clinical autonomic test battery and were also assessed for heart rate variability (HRV) under resting conditions. Sleep quality was examined using the Pittsburg Sleep Quality Index (PSQI).
Sleep duration, sleep onset latency, sleep efficiency, daytime dysfunction and global PSQI score showed significant correlations with measures of cardiac autonomic control (p < 0.05). At an optimal cut-off of ≤ 5.83 h (area under the curve: 0.76, p = 0.0003; sensitivity: 50%; specificity: 94.4%), sleep duration predicted occurrence of CAN (odds ratio, confidence interval: 0.18, 0.04–0.70; p = 0.01) in T2DM after adjusting for various clinical confounders.
Findings of the present study suggest that subjective sleep outcomes such as sleep duration, sleep onset latency, sleep efficiency, daytime dysfunction and overall sleep quality are associated with the indices of cardiac autonomic function in T2DM. Moreover, short sleep duration may be considered a predictor in the occurrence of CAN in these patients. Considering the role of sleep in the pathophysiology of CAN, sleep should be routinely examined in patients with T2DM and appropriate therapeutic interventions should be implemented particularly in case of reduced sleep duration.

View all citing articles on Scopus

View full text

Clinical notePrevalence of sleep disturbances in diabetes mellitus

Abstract

Brain Res. Bull.

Lancet

Sleep problems in patients with medical illness

BMJ

Somatic diseases and sleep complaints

Acta Med. Scand.

Quality of sleep and chronic illnesses

J. Clin. Epidemiol.

High prevalence of diabetes in an urban population of S. India

BMJ

Epidemiology of diabetes mellitus in emigrant Indians

Diabetes Bull., Res. Soc. Study Diabetes India

Sleep disorders in India

J. Assoc. Physicians India

Clinical note
Prevalence of sleep disturbances in diabetes mellitus